Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
FEMS Microbiology Ecology|November 19, 2011
Genetic diversity of Mimosa pudica rhizobial symbionts in soils of French Guiana: investigating the origin and diversity of Burkholderia phymatum and other beta-rhizobiaRavi P N Mishra, Pierre Tisseyre, Rémy Melkonian, et al.
Vaccine|January 18, 2026
A novel hypothetical protein (SAUSA300_1684) confers excellent protection against multi-drug-resistant Staphylococcus aureus infection in the murine modelPranaya M Mishra, Suman Chaudhary, Ravi S Manhas, et al.
Bioscience Reports|June 8, 2018
Structural and immunological characterization of <i>E. coli</i> derived recombinant CRM<sub>197</sub> protein used as carrier in conjugate vaccinesRavi P N Mishra, Ravi S P Yadav, Christopher Jones, et al.
Journal of Pharmaceutical Sciences|March 13, 2018
Analytical Comparability Assessments of 5 Recombinant CRM<sub>197</sub> Proteins From Different Manufacturers and Expression SystemsJohn M Hickey, Vishal M Toprani, Kawaljit Kaur, et al.
The Biochemical Journal|November 2, 2012
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2Paolo Mariotti, Enrico Malito, Marco Biancucci, et al.
The Journal of Infectious Diseases|July 26, 2012
Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in miceRavi P N Mishra, Paolo Mariotti, Luigi Fiaschi, et al.
Clinical and Vaccine Immunology : CVI|April 1, 2016
Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic ToxinLuigi Fiaschi, Benedetta Di Palo, Maria Scarselli, et al.
Vaccine|July 9, 2024
Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in HamsterJitender, B Vikram Kumar, Sneha Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureusFabio Bagnoli, Maria Rita Fontana, Elisabetta Soldaini, et al.
Pageof 2